Abbvie's HIV Drug Kaletra Fails to Help COVID-19 Patients

The coronavirus that causes COVID-19 and HIV are both RNA-based viruses, so there was hope that current HIV medications might be able to speed recovery of patients with COVID-19. Unfortunately, early evidence suggests that just isn't the case.

On Monday, Johnson & Johnson (NYSE: JNJ) said there was no evidence that its HIV drug Prezista, by itself or in combination with other HIV drugs, has any effect against SARS-CoV-2, the virus that causes COVID-19.

And on Wednesday, doctors in China published an article in The New England Journal of Medicine reporting that AbbVie's (NYSE: ABBV) HIV drug Kaletra plus standard of care wasn't any better than the standard of care.

Continue reading

Source Fool.com